Robert F. West

Internal Medicine

5620 W Thunderbird Rd Ste F1
Glendale, AZ 85306

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 22, 2016

Showing 1-1 of 1

Last Updated: 09/26/2026